Korro Bio, Inc. — Director's Dealing 2023

Jan 27, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Frequency Therapeutics, Inc. (FREQ)
CIK: 0001703647
Period of Report: 2023-01-26

Reporting Person: Arnold Wendy S (Chief People Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-26	Restricted Stock Unit	$	A	91000	Acquired		Common Stock (91000)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F2: The restricted stock units will vest in four equal annual installments beginning on January 26, 2024.